Clinical Trial Update: Bloodstream Infection of Carbapenem-Resistant Proteus Mirabilis

View source ↗

Summary

A completed clinical trial evaluating treatment for bloodstream infection caused by carbapenem-resistant Proteus mirabilis. The study, sponsored by Dokuz Eylul …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacteremia
• Carbapenem-resistant Bacterial Infection
• Proteus Mirabilis Infection

Snippet

Sponsor: Dokuz Eylul University | Conditions: Proteus Mirabilis Infection, Bacteremia | Status: COMPLETED